Example: Heart Attack

Search clinical trials for: Pramlintide

Total 54 results

NCT04252612

Recruiting

Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study

Conditions: Cutaneous Squamous Cell Carcinoma
NCT01841359

Unknown status

Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass Surgery

Conditions: Hypoglycemia; Evidence of Previous Gastric Surgery
NCT00502138

Completed

A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes

Conditions: IDDM
NCT00842075

Completed

Pramlintide in Adolescents With Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT00108004

Completed

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
NCT00444561

Completed

Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

Conditions: Overweight; Obesity
NCT00112021

Completed

A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Conditions: Obesity
NCT00042471

Completed

Evaluation of the Bioavailability of Pramlintide

Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
NCT00819234

Completed

Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin

Conditions: Obesity
NCT00291772

Completed

Continuous Subcutaneous Infusion of Pramlintide and Insulin

Conditions: Type 1 Diabetes
NCT00107107

Completed

Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 1
NCT01165944

Withdrawn

Effectiveness Study of Pramlintide to Treat Post-Transplant Diabetes Mellitus

Conditions: Diabetes Mellitus
NCT02500979

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00442767

Completed

Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00313183

Completed

A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

Conditions: Type 1 Diabetes Mellitus
NCT00505882

Withdrawn

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Conditions: Type 1 Diabetes
NCT00229658

Completed

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Conditions: Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
NCT00189514

Completed

A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Conditions: Obesity
NCT00732147

Withdrawn

Effects of Pramlintide on Endogenous Production of Very-low-density-lipoprotein (VLDL)-Triglyceride and Glucose in the Post Prandial State in T2DM

Conditions: Type 2 Diabetes
NCT01708044

Completed

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Conditions: Type 1 Diabetes
NCT01434862

Terminated

Pramlintide Combined With Model Predictive Control Algorithm

Conditions: Type 1 Diabetes Mellitus
NCT00690235

Completed

Demonstrate the Effects of Pramlintide on Weight Reduction in Schizophrenia

Conditions: Schizophrenia; Schizoaffective Disorder; Diabetes; Weight Gain
NCT00042601

Completed

Evaluation of the Effect of Pramlintide on Satiety and Food Intake

Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2
NCT03560960

Suspended

Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease

Conditions: Alzheimer Disease; Mild Cognitive Impairment
NCT00950677

Completed

The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

Conditions: Type 2 Diabetes